{"transactions":[{"id":740742,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:26:25.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":3405,"price":251.6158,"value":856751.799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26969,"source":{"system":"sec-edgar","filing":"0002001011-26-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000102/edgardoc.xml","form_type":"4"}},{"id":740741,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:26:25.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":697,"price":249.5326,"value":173924.2222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30374,"source":{"system":"sec-edgar","filing":"0002001011-26-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000102/edgardoc.xml","form_type":"4"}},{"id":740740,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:26:25.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":232,"price":248.1111,"value":57561.7752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31071,"source":{"system":"sec-edgar","filing":"0002001011-26-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000102/edgardoc.xml","form_type":"4"}},{"id":740739,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:26:25.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":257,"price":247.2237,"value":63536.4909,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31303,"source":{"system":"sec-edgar","filing":"0002001011-26-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000102/edgardoc.xml","form_type":"4"}},{"id":745417,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-09T23:41:02.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2938,"derivative":{"exercise_price":237,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":2938},"source":{"system":"sec-edgar","filing":"0002001011-26-000099","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000099/edgardoc.xml","form_type":"4"}},{"id":745416,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T23:41:02.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":31560,"source":{"system":"sec-edgar","filing":"0002001011-26-000099","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000099/edgardoc.xml","form_type":"4"}},{"id":824721,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-31T21:53:19.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 2,474 shares, which vested in full on June 6, 2019, at an exercise price of $195.91 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":114.15,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":2161},"source":{"system":"sec-edgar","filing":"0002001011-26-000036","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000036/primary_doc.xml","form_type":"4"}},{"id":824720,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T21:53:19.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":2161,"price":200.76,"value":433842.36,"ownership":{"direct":true},"balance_after":30724,"source":{"system":"sec-edgar","filing":"0002001011-26-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000036/primary_doc.xml","form_type":"4"}},{"id":824719,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T21:53:19.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":2161,"price":114.15,"value":246678.15,"ownership":{"direct":true},"balance_after":32885,"source":{"system":"sec-edgar","filing":"0002001011-26-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000036/primary_doc.xml","form_type":"4"}},{"id":1002971,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":2034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":69.51,"expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":2034},"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1002970,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 2,456 shares, which vested in full on May 25, 2018, at an exercise price of $113.5000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":66.13,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":2145},"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1002969,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":2034,"price":205.45,"value":417885.3,"ownership":{"direct":true},"balance_after":30724,"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1002968,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":2034,"price":69.51,"value":141383.34,"ownership":{"direct":true},"balance_after":32758,"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1002967,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":2145,"price":205.45,"value":440690.25,"ownership":{"direct":true},"balance_after":30724,"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1002966,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:44:42.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":2145,"price":66.13,"value":141848.85,"ownership":{"direct":true},"balance_after":32869,"source":{"system":"sec-edgar","filing":"0002001011-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000097/edgardoc.xml","form_type":"4"}},{"id":1116961,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-10T23:24:42.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":5783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5783,"derivative":{"exercise_price":105.99,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":5783},"source":{"system":"sec-edgar","filing":"0002001011-25-000044","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000044/edgardoc.xml","form_type":"4"}},{"id":1116960,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T23:24:42.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":1209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":30724,"source":{"system":"sec-edgar","filing":"0002001011-25-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000044/edgardoc.xml","form_type":"4"}},{"id":1347821,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-03T01:05:58.000Z","date":"2024-11-27","kind":"exercise","planned":false,"acquired":false,"shares":2406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 2,754 shares on April 24, 2015, which vested in full on April 24, 2016, at an exercise price of $89.7500 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":52.3,"expiration_date":"2025-04-24","underlying":"Common Stock","underlying_shares":2406},"source":{"system":"sec-edgar","filing":"0002001011-24-000093","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000093/edgardoc.xml","form_type":"4"}},{"id":1347820,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T01:05:58.000Z","date":"2024-11-27","kind":"sale","planned":false,"acquired":false,"shares":2406,"price":123.65,"value":297501.9,"ownership":{"direct":true},"balance_after":29515,"source":{"system":"sec-edgar","filing":"0002001011-24-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000093/edgardoc.xml","form_type":"4"}},{"id":1347819,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T01:05:58.000Z","date":"2024-11-27","kind":"exercise","planned":false,"acquired":true,"shares":2406,"price":52.3,"value":125833.8,"ownership":{"direct":true},"balance_after":31921,"source":{"system":"sec-edgar","filing":"0002001011-24-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000093/edgardoc.xml","form_type":"4"}},{"id":1476314,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-19T01:27:07.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5444,"derivative":{"exercise_price":80.06,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5444},"source":{"system":"sec-edgar","filing":"0002001011-24-000059","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000059/edgardoc.xml","form_type":"4"}},{"id":1476313,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:27:07.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":29515,"source":{"system":"sec-edgar","filing":"0002001011-24-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000059/edgardoc.xml","form_type":"4"}},{"id":1857836,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-13T22:55:17.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":5461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5461,"derivative":{"exercise_price":73.76,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":5461},"source":{"system":"sec-edgar","filing":"0000886163-23-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000042/edgardoc.xml","form_type":"4"}},{"id":1857835,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T22:55:17.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":1142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":28263,"source":{"system":"sec-edgar","filing":"0000886163-23-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000042/edgardoc.xml","form_type":"4"}},{"id":1858692,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:54:01.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-23-070402","document":"tm2318426-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923070402/tm2318426-6_4seq1.xml","form_type":"4"}},{"id":2053712,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T11:29:12.000Z","date":"2023-01-15","kind":"grant","acquired":true,"shares":15125,"price":4,"value":60500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $60,500 in the aggregate owed to the Reporting Person for service on the board of directors in 2022."}],"balance_after":66953,"source":{"system":"sec-edgar","filing":"0001104659-23-004007","document":"tm233517-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923004007/tm233517-3_4seq1.xml","form_type":"4"}},{"id":2076332,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-27T23:28:25.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":4484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023."}],"balance_after":4484,"derivative":{"exercise_price":67.03,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":4484},"source":{"system":"sec-edgar","filing":"0000899243-22-039404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322039404/doc4.xml","form_type":"4"}},{"id":2225333,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:01:49.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":2.62,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-22-073094","document":"tm2218674-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465922073094/tm2218674-2_4seq1.xml","form_type":"4"}},{"id":2234860,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-13T22:45:36.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4340,"derivative":{"exercise_price":79.29,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4340},"source":{"system":"sec-edgar","filing":"0000886163-22-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000079/edgardoc.xml","form_type":"4"}},{"id":2234859,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:45:36.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":1004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":26402,"source":{"system":"sec-edgar","filing":"0000886163-22-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000079/edgardoc.xml","form_type":"4"}},{"id":2508903,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-17T22:06:46.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":4835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":32.3,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":4835},"source":{"system":"sec-edgar","filing":"0000886163-21-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000136/edgardoc.xml","form_type":"4"}},{"id":2508902,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T22:06:46.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":4835,"price":161.8571,"value":782579.0785,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.36 to $164.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25398,"source":{"system":"sec-edgar","filing":"0000886163-21-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000136/edgardoc.xml","form_type":"4"}},{"id":2508901,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T22:06:46.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":4835,"price":32.3,"value":156170.5,"ownership":{"direct":true},"balance_after":30233,"source":{"system":"sec-edgar","filing":"0000886163-21-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000136/edgardoc.xml","form_type":"4"}},{"id":2680004,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-08T01:24:03.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3269,"derivative":{"exercise_price":115.39,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000886163-21-000089","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000089/edgardoc.xml","form_type":"4"}},{"id":2680003,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:24:03.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":25398,"source":{"system":"sec-edgar","filing":"0000886163-21-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000089/edgardoc.xml","form_type":"4"}},{"id":2688872,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T00:01:41.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 25% every quarter after the grant date."}],"balance_after":3750,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-21-075261","document":"tm2118079d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921075261/tm2118079d3_4seq1.xml","form_type":"4"}},{"id":2695072,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:26:18.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":5102,"price":18.58,"value":94795.16,"ownership":{"direct":true},"balance_after":51828,"source":{"system":"sec-edgar","filing":"0001104659-21-072617","document":"tm2117684-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072617/tm2117684-1_4seq1.xml","form_type":"4"}},{"id":2695071,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:26:18.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":338,"price":18.44,"value":6232.72,"ownership":{"direct":true},"balance_after":46726,"source":{"system":"sec-edgar","filing":"0001104659-21-072617","document":"tm2117684-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072617/tm2117684-1_4seq1.xml","form_type":"4"}},{"id":2991035,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T01:12:33.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."}],"balance_after":7500,"derivative":{"exercise_price":11.38,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-20-122029","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465920122029/a4.xml","form_type":"4"}},{"id":3009995,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T22:11:00.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":11111,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-20-054315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054315/doc4.xml","form_type":"4"}},{"id":3009994,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T22:11:00.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Series A Convertible Preferred Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-20-054315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054315/doc4.xml","form_type":"4"}},{"id":3009993,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-08T22:11:00.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":46388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46388},"source":{"system":"sec-edgar","filing":"0001209191-20-054315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054315/doc4.xml","form_type":"4"}},{"id":3009992,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T22:11:00.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":46388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":46388,"source":{"system":"sec-edgar","filing":"0001209191-20-054315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054315/doc4.xml","form_type":"4"}},{"id":3112437,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T22:32:59.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2468,"derivative":{"exercise_price":117.58,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":2468},"source":{"system":"sec-edgar","filing":"0000886163-20-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000075/edgardoc.xml","form_type":"4"}},{"id":3112436,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T22:32:59.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":24768,"source":{"system":"sec-edgar","filing":"0000886163-20-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000075/edgardoc.xml","form_type":"4"}},{"id":3447812,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-05T23:00:28.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date."}],"balance_after":4835,"derivative":{"exercise_price":32.3,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000886163-19-000138","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/edgardoc.xml","form_type":"4"}},{"id":3447811,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T23:00:28.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":847,"price":95.5824,"value":80958.2928,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the exercise price of options."}],"balance_after":23937,"source":{"system":"sec-edgar","filing":"0000886163-19-000138","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/edgardoc.xml","form_type":"4"}},{"id":3447810,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T23:00:28.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":2500,"price":32.3,"value":80750.0,"ownership":{"direct":true},"balance_after":24784,"source":{"system":"sec-edgar","filing":"0000886163-19-000138","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/edgardoc.xml","form_type":"4"}},{"id":3476786,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-27T19:33:27.000Z","date":"2019-06-26","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 26, 2020 or the date of the 2020 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":27000,"derivative":{"exercise_price":1.25,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000899243-19-018474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924319018474/doc4.xml","form_type":"4"}},{"id":3497901,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-07T22:46:30.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4071,"derivative":{"exercise_price":113.59,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":4071},"source":{"system":"sec-edgar","filing":"0000886163-19-000104","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000104/edgardoc.xml","form_type":"4"}},{"id":3497900,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T22:46:30.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":22284,"source":{"system":"sec-edgar","filing":"0000886163-19-000104","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000104/edgardoc.xml","form_type":"4"}},{"id":3685196,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-28T19:01:32.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":10844,"price":4.38,"value":47496.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock was acquired in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Unit Award and the restrictions lapse over a period of one year starting January 1, 2019 on a quarterly basis in arrears. Each restricted stock unit represents a contingent right to receive one share of Zafgen, Inc. common stock."}],"balance_after":31376,"source":{"system":"sec-edgar","filing":"0000899243-19-002065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924319002065/doc4.xml","form_type":"4"}},{"id":3826161,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-05T23:59:25.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":12.53,"expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":3335},"source":{"system":"sec-edgar","filing":"0000886163-18-000131","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000131/edgardoc.xml","form_type":"4"}},{"id":3826160,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-05T23:59:25.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":3335,"price":254.9601,"value":850291.9335,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.85 to $256.09, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21449,"source":{"system":"sec-edgar","filing":"0000886163-18-000131","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000131/edgardoc.xml","form_type":"4"}},{"id":3826159,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-05T23:59:25.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":3335,"price":12.53,"value":41787.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."}],"balance_after":24784,"source":{"system":"sec-edgar","filing":"0000886163-18-000131","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000131/edgardoc.xml","form_type":"4"}},{"id":3876963,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-03T22:39:26.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":195.91,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000886163-18-000096","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000096/edgardoc.xml","form_type":"4/A","original_submission_date":"2018-06-21"}},{"id":3886506,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-21T20:42:39.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":76.77,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000899243-18-017603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017603/doc4.xml","form_type":"4"}},{"id":3886505,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T20:42:39.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":21449,"source":{"system":"sec-edgar","filing":"0000899243-18-017603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017603/doc4.xml","form_type":"4"}},{"id":3901353,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T17:35:57.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 6, 2019 or the date of the 2019 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":20000,"derivative":{"exercise_price":6.79,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-015554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924318015554/doc4.xml","form_type":"4"}},{"id":3909452,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-04T23:01:31.000Z","date":"2018-06-04","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date."}],"balance_after":3335,"derivative":{"exercise_price":12.53,"expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000886163-18-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000080/edgardoc.xml","form_type":"4"}},{"id":3909451,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T23:01:31.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":4000,"price":194.5097,"value":778038.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.23 to $199.07, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20956,"source":{"system":"sec-edgar","filing":"0000886163-18-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000080/edgardoc.xml","form_type":"4"}},{"id":3909450,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T23:01:31.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":4000,"price":12.53,"value":50120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."}],"balance_after":24956,"source":{"system":"sec-edgar","filing":"0000886163-18-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000080/edgardoc.xml","form_type":"4"}},{"id":4012536,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-06T23:36:49.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":10.12,"expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":3335},"source":{"system":"sec-edgar","filing":"0000886163-18-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000042/edgardoc.xml","form_type":"4"}},{"id":4012535,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-06T23:36:49.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":3335,"price":160.9007,"value":536603.8345,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.03 to $161.94, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20956,"source":{"system":"sec-edgar","filing":"0000886163-18-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000042/edgardoc.xml","form_type":"4"}},{"id":4012534,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-06T23:36:49.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3335,"price":10.12,"value":33750.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."}],"balance_after":24291,"source":{"system":"sec-edgar","filing":"0000886163-18-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000042/edgardoc.xml","form_type":"4"}},{"id":4105229,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-05T17:01:25.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":9169,"price":5.18,"value":47495.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on a quarterly basis in arrears."}],"balance_after":20532,"source":{"system":"sec-edgar","filing":"0000899243-18-000595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924318000595/doc4.xml","form_type":"4"}},{"id":4159079,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-11-18T00:19:54.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and will fully vest on the first anniversary of the grant date."}],"balance_after":3335,"derivative":{"exercise_price":10.12,"expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000886163-17-000140","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000140/edgardoc.xml","form_type":"4"}},{"id":4159078,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-18T00:19:54.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":4000,"price":139.79,"value":559160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.75 to $139.79, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20956,"source":{"system":"sec-edgar","filing":"0000886163-17-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000140/edgardoc.xml","form_type":"4"}},{"id":4159077,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-18T00:19:54.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":4000,"price":10.12,"value":40480.0,"ownership":{"direct":true},"balance_after":24956,"source":{"system":"sec-edgar","filing":"0000886163-17-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000140/edgardoc.xml","form_type":"4"}},{"id":4273324,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-23T16:09:58.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors."}],"balance_after":14500,"derivative":{"exercise_price":3.95,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000899243-17-017077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924317017077/doc4.xml","form_type":"4"}},{"id":4303746,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-05-27T00:17:05.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":2456,"price":113.5,"value":278756.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 25, 2017.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2456,"derivative":{"exercise_price":113.5,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":2456},"source":{"system":"sec-edgar","filing":"0000886163-17-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000073/edgardoc.xml","form_type":"4"}},{"id":4303745,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-27T00:17:05.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 25, 2017  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":20956,"source":{"system":"sec-edgar","filing":"0000886163-17-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000073/edgardoc.xml","form_type":"4"}},{"id":4448352,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T20:07:38.000Z","date":"2017-02-13","kind":"grant","acquired":true,"shares":11363,"price":4.18,"value":47497.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2017 on a quarterly basis in arrears."}],"balance_after":11363,"source":{"system":"sec-edgar","filing":"0000899243-17-004091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216074/000089924317004091/doc4.xml","form_type":"4"}},{"id":567163,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-10-17T13:02:17.000Z","date":"2007-10-15","kind":"grant","acquired":true,"shares":214,"price":25,"value":5350.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":57875,"derivative":{"underlying":"Common Stock","underlying_shares":214},"source":{"system":"sec-edgar","filing":"0000078003-07-000282","document":"lam1615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000282/lam1615.xml","form_type":"4"}},{"id":568095,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-10-02T16:42:08.000Z","date":"2007-09-28","kind":"grant","acquired":true,"shares":232,"price":24.43,"value":5667.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":57661,"derivative":{"underlying":"Common Stock","underlying_shares":232},"source":{"system":"sec-edgar","filing":"0000078003-07-000264","document":"lam1598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000264/lam1598.xml","form_type":"4"}},{"id":569002,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-09-17T22:02:24.000Z","date":"2007-09-14","kind":"grant","acquired":true,"shares":226,"price":24.29,"value":5489.54,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":57429,"derivative":{"underlying":"Common Stock","underlying_shares":226},"source":{"system":"sec-edgar","filing":"0000078003-07-000236","document":"lam1583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000236/lam1583.xml","form_type":"4"}},{"id":569965,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-09-04T17:54:42.000Z","date":"2007-08-31","kind":"grant","acquired":true,"shares":185,"price":24.84,"value":4595.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":57203,"derivative":{"underlying":"Common Stock","underlying_shares":185},"source":{"system":"sec-edgar","filing":"0000078003-07-000221","document":"lam1573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000221/lam1573.xml","form_type":"4"}},{"id":571388,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-08-17T12:54:25.000Z","date":"2007-08-15","kind":"grant","acquired":true,"shares":910,"price":23.53,"value":21412.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":57018,"derivative":{"underlying":"Common Stock","underlying_shares":910},"source":{"system":"sec-edgar","filing":"0000078003-07-000208","document":"lam1564.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000208/lam1564.xml","form_type":"4"}},{"id":574018,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-08-01T21:20:23.000Z","date":"2007-07-31","kind":"grant","acquired":true,"shares":239,"price":23.51,"value":5618.89,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":56108,"derivative":{"underlying":"Common Stock","underlying_shares":239},"source":{"system":"sec-edgar","filing":"0000078003-07-000186","document":"lam1555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000186/lam1555.xml","form_type":"4"}},{"id":575455,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-07-17T14:47:05.000Z","date":"2007-07-13","kind":"grant","acquired":true,"shares":215,"price":25.91,"value":5570.65,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":55869,"derivative":{"underlying":"Common Stock","underlying_shares":215},"source":{"system":"sec-edgar","filing":"0000078003-07-000175","document":"lam1546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000175/lam1546.xml","form_type":"4"}},{"id":576388,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-07-03T14:45:36.000Z","date":"2007-06-29","kind":"grant","acquired":true,"shares":217,"price":25.57,"value":5548.69,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":55654,"derivative":{"underlying":"Common Stock","underlying_shares":217},"source":{"system":"sec-edgar","filing":"0000078003-07-000165","document":"lam1534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000165/lam1534.xml","form_type":"4"}},{"id":576387,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-07-03T14:45:36.000Z","date":"2007-06-29","kind":"tax_withholding","acquired":false,"shares":6264,"price":25.57,"value":160170.48,"ownership":{"direct":true},"balance_after":383190,"source":{"system":"sec-edgar","filing":"0000078003-07-000165","document":"lam1534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000165/lam1534.xml","form_type":"4"}},{"id":577516,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-06-18T20:38:41.000Z","date":"2007-06-15","kind":"grant","acquired":true,"shares":212,"price":26.47,"value":5611.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":55437,"derivative":{"underlying":"Common Stock","underlying_shares":212},"source":{"system":"sec-edgar","filing":"0000078003-07-000138","document":"lam1521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000138/lam1521.xml","form_type":"4"}},{"id":577515,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-06-18T20:38:41.000Z","date":"2007-06-15","kind":"gift","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":389454,"source":{"system":"sec-edgar","filing":"0000078003-07-000138","document":"lam1521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000138/lam1521.xml","form_type":"4"}},{"id":577514,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-06-18T20:38:41.000Z","date":"2007-06-15","kind":"sale","acquired":false,"shares":36066,"price":26.48,"value":955027.68,"ownership":{"direct":true},"balance_after":429454,"source":{"system":"sec-edgar","filing":"0000078003-07-000138","document":"lam1521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000138/lam1521.xml","form_type":"4"}},{"id":578737,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-06-01T18:36:30.000Z","date":"2007-05-31","kind":"grant","acquired":true,"shares":192,"price":27.49,"value":5278.08,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":55225,"derivative":{"underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0000078003-07-000127","document":"lam1515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000127/lam1515.xml","form_type":"4"}},{"id":580017,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-05-16T19:54:23.000Z","date":"2007-05-15","kind":"grant","acquired":true,"shares":777,"price":27.1,"value":21056.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":55033,"derivative":{"underlying":"Common Stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0000078003-07-000117","document":"lam1506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000117/lam1506.xml","form_type":"4"}},{"id":581894,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-05-01T20:41:49.000Z","date":"2007-04-30","kind":"grant","acquired":true,"shares":207,"price":26.46,"value":5477.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":54256,"derivative":{"underlying":"Common Stock","underlying_shares":207},"source":{"system":"sec-edgar","filing":"0000078003-07-000097","document":"lam1495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000097/lam1495.xml","form_type":"4"}},{"id":582724,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-04-17T15:22:05.000Z","date":"2007-04-13","kind":"grant","acquired":true,"shares":198,"price":26.67,"value":5280.66,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":54049,"derivative":{"underlying":"Common Stock","underlying_shares":198},"source":{"system":"sec-edgar","filing":"0000078003-07-000070","document":"lam1473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000070/lam1473.xml","form_type":"4"}},{"id":583230,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-04-03T15:28:58.000Z","date":"2007-03-30","kind":"grant","acquired":true,"shares":205,"price":25.26,"value":5178.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":53851,"derivative":{"underlying":"Common Stock","underlying_shares":205},"source":{"system":"sec-edgar","filing":"0000078003-07-000061","document":"lam1459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000061/lam1459.xml","form_type":"4"}},{"id":583387,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-03-27T20:06:30.000Z","date":"2007-03-23","kind":"tax_withholding","acquired":false,"shares":13710,"price":25.66,"value":351798.6,"ownership":{"direct":true},"balance_after":461822,"source":{"system":"sec-edgar","filing":"0000078003-07-000050","document":"lam1451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000050/lam1451.xml","form_type":"4"}},{"id":583709,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-03-19T18:24:00.000Z","date":"2007-03-15","kind":"grant","acquired":true,"shares":3927,"price":24.99,"value":98135.73,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":53646,"derivative":{"underlying":"Common Stock","underlying_shares":3927},"source":{"system":"sec-edgar","filing":"0000078003-07-000042","document":"lam1442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000042/lam1442.xml","form_type":"4"}},{"id":585313,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2007-02-26T22:12:34.000Z","date":"2007-02-22","kind":"grant","acquired":true,"shares":177500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":177500,"derivative":{"exercise_price":25.87,"exercise_date":"2010-02-22","expiration_date":"2017-02-21","underlying":"Common Stock","underlying_shares":177500},"source":{"system":"sec-edgar","filing":"0000078003-07-000028","document":"lam1432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000028/lam1432.xml","form_type":"4"}},{"id":585312,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-02-26T22:12:34.000Z","date":"2007-02-22","kind":"tax_withholding","acquired":false,"shares":19974,"price":25.87,"value":516727.38,"ownership":{"direct":true},"balance_after":475158,"source":{"system":"sec-edgar","filing":"0000078003-07-000028","document":"lam1432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000028/lam1432.xml","form_type":"4"}},{"id":585311,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-02-26T22:12:34.000Z","date":"2007-02-22","kind":"grant","acquired":true,"shares":56040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the earn-out of Performance-Contingent Shares."}],"balance_after":495132,"source":{"system":"sec-edgar","filing":"0000078003-07-000028","document":"lam1432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000028/lam1432.xml","form_type":"4"}},{"id":585310,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-02-26T22:12:34.000Z","date":"2007-02-22","kind":"grant","acquired":true,"shares":17730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the grant of restricted stock units."}],"balance_after":439092,"source":{"system":"sec-edgar","filing":"0000078003-07-000028","document":"lam1432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000028/lam1432.xml","form_type":"4"}},{"id":586686,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2007-02-08T20:40:03.000Z","date":"2007-02-07","kind":"exercise","acquired":false,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became exercisable in 5 equal annual installments beginning on August 28,1998."}],"balance_after":0,"derivative":{"exercise_price":18.35,"expiration_date":"2007-08-27","underlying":"Common Stock","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0000078003-07-000019","document":"lam1423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000019/lam1423.xml","form_type":"4"}},{"id":586685,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-02-08T20:40:03.000Z","date":"2007-02-07","kind":"sale","acquired":false,"shares":13800,"price":26.54,"value":366252.0,"ownership":{"direct":true},"balance_after":421101,"source":{"system":"sec-edgar","filing":"0000078003-07-000019","document":"lam1423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000019/lam1423.xml","form_type":"4"}},{"id":586684,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2007-02-08T20:40:03.000Z","date":"2007-02-07","kind":"exercise","acquired":true,"shares":13800,"price":18.35,"value":253230.0,"ownership":{"direct":true},"balance_after":434901,"source":{"system":"sec-edgar","filing":"0000078003-07-000019","document":"lam1423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000019/lam1423.xml","form_type":"4"}},{"id":589653,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":17238,"kind":"person","name":"LAMATTINA JOHN L","position":1,"cik":"0001216074","reported_name":"LAMATTINA JOHN L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Phantom Stock Units SSP","published_at":"2007-01-03T23:25:54.000Z","date":"2006-12-29","kind":"grant","acquired":true,"shares":200,"price":25.9,"value":5180.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":49161,"derivative":{"underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0000078003-07-000008","document":"lam1409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000008/lam1409.xml","form_type":"4"}}],"next_cursor":"2007-01-03T23:25:54.000000Z,589653"}